A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...

Micron changed its guidance today, raising forecasts for revenue and profit. The company earned only $0.70 last year per ...

NYSE:SSD 1 Year Share Price vs Fair Value Explore Simpson Manufacturing's Fair Values from the Community and ...

Peloton ( PTON 5.23%) had its initial public offering ( IPO) in September 2019, and the stock has taken investors on a wild ...

Analysts said trade war-related issues are pressuring the U.S./Mexico remittance corridor, lowering the value of the ...

Ross Stores stock shows strong fundamentals and capital returns. But here's why its valuation and mixed results limit the ...

Liquidia Corp (NASDAQ:LQDA) is set to release its Q2 2025 earnings on Aug 12, 2025. The consensus estimate for Q2 2025 ...

GSK’s share price is still significantly down on the year, despite very robust H1 results, leaving it looking extremely ...

Stellus Capital offers an 11.2% dividend yield, but concerns about portfolio quality, NAV premium, and borrower risks suggest ...

The Entain share price has been climbing since upgraded guidance earlier this year, and the first-half saw an impressive performance. The post Entain H1 results boost barely moves the share price — is ...

BDL is showing strong technical support near ₹1,480– ₹1,500, with potential for bullish reversal if it sustains above ₹1,500.

Revenues of $109.8 million compared to $95.9 million in the prior year periodPretax income of $7.0 million compared to $6.7 ...